10Williams DO, Abbott JD, Kip KE, et al. Outcomes of 6906 Patients Undergoing Peroutaneous Coronary Intervention in the Era of Drug-Eluting Stents. Report of the DEScover Registry. Circulation,2006,114:2154-2162.
7Longstreth K L, Wertz jr R, et al. High-dose clopidogrel loading in percutaneous coronary intervention [J]. Ann Pharmaco ther, 2005,39:918- 922.
8Von Beckerath N, Taubert D, Pogatsam Urray G, et al. Ab- sorption, metabolization, and antiplatelet effects of 300-, 600-, and 900mg loading doses of clopidogrel. Results of the ISAR- CHOICE (intracoronary stenting and antithrombotic regimen: Choose between 3 high oral doses for immediate clopidogrel effect) Trial [J]. Circulation, 2005,112:2946- 2950.
9Patti G, Colonna G, Pasceri V, et al. Randomized trial of high loading dose of clopidogrel for reduction of periproeedural myo- cardial infarction in patients undergoing coronary intervention: results from the ARM YDA- 2 (Antiplatelet therapy for reduc- tion of myocardial damage during angioplasty) study [J]. Circu- lation, 2005, 111: 2099-2106.
10Gratsianskii N A. Clopidogrel should be added to aspirin for at least 1 year after percutaneous coronary interventions (CREDO) while before them its loading dose can reach 600 mg (ISAR- COOL)[J]. Kardiologiia, 2003,43 : 71-73.
